- Home
- BLBD vs IMCR Comparison
BLBD vs IMCR Comparison
Compare BLBD & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBD
- IMCR
- Stock Information
- Founded
- BLBD 1927
- IMCR 2008
- Country
- BLBD United States
- IMCR United Kingdom
- Employees
- BLBD N/A
- IMCR N/A
- Industry
- BLBD Construction/Ag Equipment/Trucks
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLBD Consumer Discretionary
- IMCR Health Care
- Exchange
- BLBD Nasdaq
- IMCR Nasdaq
- Market Cap
- BLBD 1.5B
- IMCR 1.7B
- IPO Year
- BLBD N/A
- IMCR 2021
- Fundamental
- Price
- BLBD $40.02
- IMCR $30.22
- Analyst Decision
- BLBD Strong Buy
- IMCR Buy
- Analyst Count
- BLBD 7
- IMCR 13
- Target Price
- BLBD $60.64
- IMCR $65.18
- AVG Volume (30 Days)
- BLBD 667.7K
- IMCR 311.8K
- Earning Date
- BLBD 02-05-2025
- IMCR 02-26-2025
- Dividend Yield
- BLBD N/A
- IMCR N/A
- EPS Growth
- BLBD 327.03
- IMCR N/A
- EPS
- BLBD 3.16
- IMCR N/A
- Revenue
- BLBD $1,347,154,000.00
- IMCR $296,312,000.00
- Revenue This Year
- BLBD $10.68
- IMCR $29.19
- Revenue Next Year
- BLBD $8.58
- IMCR $12.56
- P/E Ratio
- BLBD $12.29
- IMCR N/A
- Revenue Growth
- BLBD 18.92
- IMCR 25.09
- 52 Week Low
- BLBD $24.09
- IMCR $27.69
- 52 Week High
- BLBD $59.40
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- BLBD 45.55
- IMCR 48.09
- Support Level
- BLBD $38.30
- IMCR $27.77
- Resistance Level
- BLBD $45.10
- IMCR $29.29
- Average True Range (ATR)
- BLBD 1.89
- IMCR 1.48
- MACD
- BLBD -0.24
- IMCR -0.06
- Stochastic Oscillator
- BLBD 24.87
- IMCR 52.27
About BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It has its operations in two segments. The Bus segment involves the design, engineering, manufacture and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. It carries its operations in the United States, Canada, and the rest of the world. The majority of its sales are derived from the United States through its bus manufacturing business.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.